Cencora is a pharmaceutical sourcing and distribution services company. Co. is organized based upon the products and services it provides to its customers. Co.'s segment are: U.S. Healthcare Solutions, which distributes a provision of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers; and International Healthcare Solutions, which distributes pharmaceuticals, other healthcare products, and related services to healthcare providers as well as engages in specialty transportation and logistics provider for the biopharmaceutical industry.
When researching a stock like Cencora, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from COR Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for COR stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the COR 200 day moving average ("COR 200 DMA"), while one of the most popular "shorter look-backs" is the COR 50 day moving average ("COR 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Cencora. |
Free COR Email Alerts:
Video: Technical Analysis